{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:53:52Z","timestamp":1648821232937},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/cnq.0000000000000017","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T20:49:06Z","timestamp":1393879746000},"page":"188-198","source":"Crossref","is-referenced-by-count":0,"title":["Take a Deep Breath"],"prefix":"10.1097","volume":"37","author":[{"given":"Jamie","family":"Beachem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Litton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1016\/j.amjcard.2012.12.002","article-title":"Pulmonary arterial hypertension: new insight into the optimal role of current and emerging prostacyclin therapies.","volume":"111","author":"Waxman","year":"2013","journal-title":"Am J Cardiol"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanism of disease: pulmonary arterial hypertension.","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur Respir J"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension.","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary arterial hypertension of the newborn in the era before nitric oxide: practice variation and outcomes.","volume":"10","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"issue":"6","key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/NAN.0b013e31818c09b1","article-title":"Advances in prostanoid infusion therapy for pulmonary arterial hypertension.","volume":"31","author":"Doran","year":"2008","journal-title":"J Infusion Nurs"},{"issue":"2","key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pcad.2012.07.002","article-title":"WHO group 1 pulmonary arterial hypertension: current and investigative therapies.","volume":"55","author":"Ventetuolo","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (early study): a double-blind, randomised controlled trial.","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension.","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2011.03.037","article-title":"Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.","volume":"108","author":"Klinger","year":"2011","journal-title":"Am J Cardiol"},{"issue":"21","key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.jacc.2009.07.033","article-title":"Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.","volume":"54","author":"Oudiz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.10-0969","article-title":"Long-term treatment with sildenafil citrate in pulmonary arterial hypertension the super-2 study.","volume":"140","author":"Rubin","year":"2011","journal-title":"Chest"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension.","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1755-5922.12008","article-title":"Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.","volume":"31","author":"Bourge","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"122","key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09059180.00006411","article-title":"Looking to the future: a new decade of pulmonary arterial hypertension therapy.","volume":"20","author":"McLaughlin","year":"2011","journal-title":"Eur Respir Rev"},{"issue":"2","key":"R25-7-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1089253207301356","article-title":"Current therapies for pulmonary arterial hypertension.","volume":"11","author":"Takaoka","year":"2007","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R26-7-20210126","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.athoracsur.2008.05.049","article-title":"Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension.","volume":"86","author":"Toyoda","year":"2008","journal-title":"Soc Thorac Surg"}],"container-title":["Critical Care Nursing Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CNQ.0000000000000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:54Z","timestamp":1620949794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002727-201404000-00007"}},"subtitle":["Understanding Pulmonary Arterial Hypertension"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cnq.0000000000000017","relation":{},"ISSN":["0887-9303"],"issn-type":[{"value":"0887-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}